Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$7.36 - $10.89 $2.38 Million - $3.53 Million
-323,775 Reduced 40.77%
470,285 $4.95 Million
Q2 2023

Aug 14, 2023

SELL
$5.92 - $12.72 $444,000 - $954,000
-75,000 Reduced 8.63%
794,060 $9.16 Million
Q4 2022

Feb 14, 2023

BUY
$8.05 - $11.58 $1.58 Million - $2.27 Million
196,400 Added 29.2%
869,060 $7.57 Million
Q3 2022

Nov 14, 2022

SELL
$3.31 - $13.06 $452,923 - $1.79 Million
-136,835 Reduced 16.9%
672,660 $6.73 Million
Q2 2022

Aug 15, 2022

SELL
$6.0 - $9.37 $3.6 Million - $5.62 Million
-600,000 Reduced 42.57%
809,495 $7.05 Million
Q1 2022

May 16, 2022

BUY
$6.64 - $12.85 $145,303 - $281,196
21,883 Added 1.58%
1,409,495 $11.3 Million
Q4 2021

Feb 14, 2022

BUY
$10.81 - $14.38 $2.06 Million - $2.73 Million
190,156 Added 15.88%
1,387,612 $18.7 Million
Q3 2021

Nov 15, 2021

SELL
$11.58 - $15.46 $11.1 Million - $14.8 Million
-954,936 Reduced 44.37%
1,197,456 $15.6 Million
Q1 2021

May 17, 2021

SELL
$10.24 - $14.6 $199,649 - $284,656
-19,497 Reduced 0.9%
2,152,392 $24.1 Million
Q4 2020

Feb 16, 2021

BUY
$9.67 - $12.05 $4.42 Million - $5.51 Million
457,265 Added 26.67%
2,171,889 $23.4 Million
Q3 2020

Nov 16, 2020

BUY
$8.73 - $15.15 $15 Million - $26 Million
1,714,624 New
1,714,624 $18.2 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $522M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.